Search - tctmd.com

Displaying 581 - 600 of 628

Sort: Relevancy | Date

News Daily News

‘Appropriate’ Use of Revascularization Varies in Stable CAD Patients

Caitlin E. Cox

October 12, 2012

Presentation

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Presenter: Dennis T. Ko

October 10, 2012

News Daily News

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

L.A. McKeown

September 12, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Daily News

La Masa Corporal Magra Ofrece una Nueva Evidencia a la ‘Paradoja de la Obesidad’ de los Pacientes con EAC

L.A. McKeown

September 12, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Daily News

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

L.A. McKeown

August 23, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

July 12, 2012

News Daily News

Perfusion Imaging Guidance for Revascularization Improves Outcomes

July 11, 2012

News Daily News

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

June 25, 2012

News Daily News

La Revascularización Incompleta hace que los Diabéticos corran un Mayor Riesgo de Episodios a Largo Plazo

Leah Lawrence

April 20, 2012

News Daily News

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

Leah Lawrence

April 20, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

April 10, 2012

Presentation

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Presenter: Deepak L. Bhatt

April 09, 2012

Advertisement

‘Appropriate’ Use of Revascularization Varies in Stable CAD Patients

Association Between Appropriateness of Coronary Revascularization and Clinical Outcomes in Patients with Stable CAD

Lean Body Mass Adds New Evidence to ‘Obesity Paradox’ in CAD Patients

Dabigatran Usage up, Both for A-fib and Off-Label Indications

La Masa Corporal Magra Ofrece una Nueva Evidencia a la ‘Paradoja de la Obesidad’ de los Pacientes con EAC

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

SORT OUT III: Higher Risk of Very Late Stent Thrombosis with Cypher vs. Endeavor

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

Perfusion Imaging Guidance for Revascularization Improves Outcomes

Coronary Reactivity Testing Relatively Safe in High-Risk Women Without CAD

La Revascularización Incompleta hace que los Diabéticos corran un Mayor Riesgo de Episodios a Largo Plazo

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Análisis Genético CHARISMA: Las Variantes del CYP2C19 Influyen Poco a Nivel Clínico

Relationship Between CYP2C19 Polymorphisms and Ischemic and Bleeding Outcomes in Stable Outpatients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content